Summary Slide.png (120.56 kB)

A Framework for Estimating the Eligible Patient Population for New Migraine Acute Therapies in the United States

media

posted on 2021-07-14, 12:41 authored by Linda Harris, Gilbert L’Italien, Tom O’Connell, Zacharia Hasan, Susan Hutchinson, Sylvia Lucas

Article full text

The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

History

References

https://link.springer.com/article/10.1007/s12325-021-01781-z

Usage metrics

Read the peer-reviewed publication

A Framework for Estimating the Eligible Patient Population for New Migraine Acute Therapies in the United States

Advances in Therapy

Keywords

Migraine CGRP 5-HT1F Rimegepant Ubrogepant Lasmiditan Triptan Eligibility Budget impact Model

Licence

CC BY-NC 4.0

A Framework for Estimating the Eligible Patient Population for New Migraine Acute Therapies in the United States

History

References

Usage metrics

Read the peer-reviewed publication

Categories

Keywords

Licence

Exports